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Summary G-401A polymorphism in RANTES promoter was associated with near-fatal
asthma and atopic dermatitis in children. We studied whether gain-of-function
mutations in RANTES gene were associated with asthma and atopy-related traits in
Chinese children. Plasma total and aeroallergen-specific IgE concentrations were
measured using micro-particle immunoassay and fluorescent enzyme immunoassay,
respectively. Restriction fragment length polymorphism was used to genotype
RANTES G-401A and C-28G. One hundred and twenty-nine asthmatic children and 66
controls were recruited. Their mean logarithmic plasma total IgE concentrations
were 2.53 and 1.98, respectively (Po0:0001). RANTES G-401A was not associated
with physician-diagnosed asthma (P ¼ 0:408). However, RANTES -401A allele was
significantly associated with IgE sensitization to cat (odds ratio 2.35; 95% CI 1.15–
4.77; P ¼ 0:010). Those homozygous for -401A had higher plasma cat-specific IgE
levels (P ¼ 0:034). Subjects having -401A were also more likely to have mold-specific
IgE (odds ratio 3.82; 95% CI 1.24–12.14; P ¼ 0:007). On spirometry, those with -401A/
A had lower forced expiratory volume in 1-s (FEV1; P ¼ 0:044). RANTES C-28G was
not associated with any outcome in this study. In conclusion, the gain-of-function
mutation at -401 of RANTES promoter is associated with sensitization to cat and mold
allergens and FEV1 in Chinese children.
& 2004 Elsevier Ltd. All rights reserved.
Introduction
Regulated on activation, normal T cell expressed
and secreted (RANTES) is one of the most exten-
sively studied C–C chemokines in allergic inflam-
mation.1 Elevated RANTES level was detected in
bronchoalveolar lavage fluid of patients with acute
asthma and following allergen challenge.2–4 Gen-
ome-wide screen in African Americans also linked
asthma to the C–C chemokine gene cluster on
chromosome 17p12-17q11.2.5 Two mutations at
-401 and -28 in RANTES resulted in increased
transcriptional activity of the mutant promoter.6–9
In Caucasian adults, RANTES G-401A was associated
with asthma, skin test positivity and forced
expiratory volume in 1-s (FEV1).
10 This polymorph-
ism was also associated with atopic dermatitis in
German children.9 This study aims at investigating
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the relation between RANTES promoter polymorph-
isms and various asthma and atopy phenotypes in
Chinese children.
Patients and methods
Subjects
This study recruited unrelated Chinese children
aged 5–18 years with asthma diagnosed according
to American Thoracic Society criteria.11 Briefly,
these patients had X6-month history of recurrent
cough, dyspnea or wheezing that was relieved by
bronchodilator and reversibility and/or hyperreac-
tivity on pulmonary function studies. These asth-
matic patients were recruited from pediatric clinics
of a university teaching hospital. Non-allergic
controls were recruited among those referred for
assessment of minor complaints. All subjects were
free from infection for four weeks before study.
Clinical Research Ethics Committee of our univer-
sity approved this study.
Clinical assessments
Following written consent, plasma samples were
collected from subjects for total IgE by micro-
particle immunoassay (IMx analyser, Abbott Labora-
tories, Abbott Park, IL, USA), and specific IgE to
locally relevant aeroallergens 12 (D. pteronyssinus,
cat, dog, cockroaches and mixed molds) by
fluorescent enzyme immunoassay (AutoCAP system,
Pharmacia Diagnostics AB, Uppsala, Sweden). Atopy
is defined by X one aeroallergen-specific IgE. All
asthmatics also underwent simple spirometry, and
results were compared with local references.13
Genotyping RANTES polymorphisms
RANTES G-401A and C-28G were genotyped by
restriction fragment length polymorphism as de-
scribed.6,7 Briefly, the primers for G-401A were (F)
50-GCC TCA ATT TAC AGT GTG-30 and (R) 50-TGC TTA
TTC ATT ACA GAT GTT-30, and those for C-28G were
(F) 50-ACA GAG ACT CGA ATT TCC GGA-30 and (R) 50-
CCA CGT GCT GTC TTG ATC CTC-30. Fifty nanograms
genomic DNA was amplified with 25 pmol of each
primer and 1 unit Taq polymerase (MBI Fermentas,
Amherst, NY, USA) or 0.75 unit Ampli Taq Gold
(Applied Biosystems, Foster City, CA, USA). Poly-
merase chain reaction consisted of 951C for 5min,
38 cycles of 941C for 45 s, 531C for 45 s and 721C for
45 s, and 721C for 7min. MaeIII cut the product into
two bands (112 and 23 bp) for -401G, whereas Mnl1
digested the product into three bands (126, 27 and
20 bp) for -28C. Genotypes of 8 random samples
from each of G-401A and C-28G were confirmed by
direct sequencing using BigDye Terminator Cycle
sequencing kit (Applied Biosystems, Foster City, CA,
USA).
Statistical analysis
The demographic and clinical data were analyzed
using Student t-test, w2 or Fisher exact test as
appropriate. The distribution of RANTES genotypes
or alleles between patients and controls were
analyzed by w2 or Fisher exact test. Plasma IgE
concentrations and FEV1 between different RANTES
genotypes were analyzed by analysis of variance or
Kruskal–Wallis test. P-values less than 0.05 were
considered significant Fig. 1.
Results
One hundred twenty-nine asthmatics and 66 con-
trols, with mean (SD) ages of 9.9 (3.4) years and
10.5 (4.6) years (P ¼ 0:35), were recruited. Eighty-
two (64%) patients and 41 (62%) controls were
males (P ¼ 0:84). Table 1 summarizes the clinical
characteristics of our patients. The mean (SD) log-
transformed total IgE concentration was 2.53
(0.59) kIU/l in patients and 1.98 (0.78) kIU/l in
controls (Po0:0001). Ninety-seven (75%) asth-
matics and 29 (44%) controls had increased plasma
total IgE (OR 3.87, 95% CI 1.97–7.63; Po0:0001),
and 113 (88%) patients and 33 (50%) controls were
atopic (OR 7.06, 95% CI 3.28-15.37; Po0:0001).
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Figure 1 Boxplots of percent FEV1 versus RANTES G-
401A genotypes. The median percent FEV1 was provided
for each of the three genotypes (P ¼ 0:044 by Kruskal–
Wallis test).
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Asthma was also significantly associated with
sensitization to D. pteronyssinus (OR 5.40, 95% CI
2.60–11.29; Po0:0001) and cat (OR 5.24, 95% CI
1.11–33.80; P ¼ 0:017).
The distributions of RANTES -401 and -28 alleles
followed Hardy–Weinberg equilibrium. Table 2
summarizes genotype and allele frequencies of
RANTES G-401A in various asthma or atopy pheno-
types. RANTES-401A was associated with the pre-
sence of cat-specific IgE (OR 2.35; 95% CI 1.15–
4.77; P ¼ 0:010). Plasma cat-specific IgE concen-
trations were higher in subjects with -401A/A as
compared to G/A and G/G (P ¼ 0:034 for trend).
Sensitization to mixed molds was also more
common in subjects carrying -401A (OR 3.82; 95%
CI 1.24–12.14; P ¼ 0:007). Spirometrically, 20 (16%)
asthmatics had FEV1p80%. Fig. 1 shows that FEV1
was significantly lower in patients with -401A/A.
RANTES -28G was present in 10% patients and 9%
controls. None of them was homozygous for this
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Table 1 Clinical characteristics and lung functions of our 129 asthmatic patients.
Characteristics Results
Demographic data
Age at assessment in years, mean (SD) 9.9 (3.4)
Male gender, n (%) 82 (64)
Coexisting physician-diagnosed allergic rhinitisn, n (%) 104 (81)
Coexisting physician-diagnosed atopic dermatitisn, n (%) 45 (35)
Details on asthma prophylaxis
Number of patients receiving inhaled corticosteroids, n (%) 73 (57)
Median (range) daily dose of inhaled beclomethasone dipropionate or equivalent in mg 200(100–1000)
Median (interquartile range) FEV1, % predicted 98 (85–111)
nThe diagnoses of allergic rhinitis and atopic dermatitis were made according to the criteria listed in references,14,15
respectively.
Table 2 The relationship between asthma or atopy phenotypes and RANTES G-401A.
401 Genotypes 401 Alleles
Groups G/G (%) G/A (%) A/A (%) P-valuen A (%) OR (95% CI) P-valuen
Allergen sensitization (positive
RAST)w
Cat-sensitized 7 (35) 6 (30) 7 (35) 0.008 20 (50) 2.35 (1.15–4.77) 0.010
With not cat-sensitized 88 (51) 68 (39) 18 (10) 104 (30) 1.0
Mixed mold-sensitized 1 (13) 4 (50) 3 (38) 0.037 10 (63) 3.82 (1.24–12.14) 0.007
With not mixed mold-
sensitized
95 (51) 69 (37) 22 (12) 113 (30) 1.0
All asthmatic patients 60 (47) 53 (41) 16 (12) 0.408 85 (33) 1.26 (0.78–2.05) 0.322
Asthmatics with X1 positive
RAST
54 (48) 45 (40) 14 (12) 0.525 73 (32) 1.23 (0.75–2.02) 0.398
With all control children 37 (56) 21 (32) 8 (12) 37 (28) 1.0
Increased serum total IgEz 63 (50) 47 (37) 16 (13) 0.957 79 (31) 1.01 (0.63–1.62) 0.969
With normal serum total IgE 34 (49) 27 (39) 8 (12) 43 (31) 1.0
Atopic subjects (with X 1
positive RAST)
72 (49) 55 (38) 19 (13) 0.874 93 (32) 1.11 (0.66–1.89) 0.677
With non-atopic subjects 25 (51) 19 (39) 5 (10) 29 (30) 1.0
A, mutant -401 allele; CI, confidence interval; G, wild-type -401 allele, OR, odds ratio.
nAnalyzed between two groups by Pearson w2 or Fisher exact test.
wResults for D. pteronyssinus, dog and cockroach sensitization were insignificant and thus not included.
zCompared with age-matched upper limits of reference ranges (5-6 years: 120 kIU/l; 6-7 years: 160 kIU/l;X 8 years: 180 kIU/l)
for local Chinese children.
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mutant, and C-28G was not associated with any
asthma or atopy phenotype (results not shown).
Discussion
This study shows for the first time that RANTES
polymorphism is linked to allergen sensitization and
asthma severity as assessed by FEV1. RANTES G-
401A is associated with sensitization to cat and
mold allergens. Asthmatic children with -401A/A
also have lower FEV1. RANTES C-28G is not
associated with any outcome variable in our
Chinese children. Fryer and colleagues showed
similarly a significant association between RANTES
G-401A and skin test positivity to aeroallergens and
asthma diagnosis in Caucasians.10 In contrast, Yao
and colleagues found that RANTES -28G but not -
401A was significantly associated with near-fatal
asthma in Chinese children. RANTES -28G was also
associated with peripheral eosinophilia and bron-
chial hyperresponsiveness.16 These discrepant ef-
fects might be explained by tight linkage
disequilibrium between G-401A and C-28G.17 The
importance of RANTES on asthma and atopy was
further supported by the finding that its blood level
was increased in patients with severe asthmatic
exacerbation.3,18
RANTES -401A was found in 9–16% of Cauca-
sians,6,9,10 but its frequency was much higher in
Chinese (25%) and Japanese (33%).16,17 RANTES -
28G, another gain-of-function mutation, was pre-
sent in 4% of Caucasians, 12% of Chinese and 12–17%
of Japanese.7,8,16,17 In the present study, -401A was
present in 28% of controls whereas -28G was
detected in 9% of them, and these figures were
similar to those of Chinese and Japanese but much
higher than in healthy Caucasians. Further studies
are needed to delineate the allele frequencies for
RANTES -401 and -28 in different ethnic groups.
The main weakness of this study relates to the
sample size. There has not been any report on
allele frequencies of RANTES G-401A and C-28G in
Chinese at the time of this study, and this made
sample size estimation difficult. Retrospective
analysis showed that our sample size was able to
detect an odds ratio of 2.6 for G-401A with asthma
with 80% power and 95% confidence. This study may
thus be underpowered in detecting any association
between G-401A and rare outcomes. Despite this,
this study detects an association between this
polymorphism and FEV1 and aeroallergen sensitiza-
tion.
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